Rubius Therapeutics, Inc. (Nasdaq: RUBY) Rings The Nasdaq Stock Market Opening Bell
Rubius Therapeutics, Inc. (Nasdaq: RUBY), a company pioneering the creation of life-changing, ready-to-use, cellular therapies for patients with severe diseases, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).
Format
JPEG
Source
Nasdaq, Inc.